Pennington Biomedical Research Center to Get New Director
The Baton Rouge center will transition to new leadership on June 30, 2027, impacting local research partnerships.
Updated on Oct. 29, 2026 in People
Live Poll
Should major research centers prioritize local health needs when choosing their leadership?
Louisiana State University will appoint Petter Bjornstad as the new executive director of the Pennington Biomedical Research Center on June 30, 2027. Bjornstad currently leads the University of Washington Medicine Diabetes Institute and will succeed interim executive director Jennifer Rood.
Why it matters
The leadership change at the center arrives as the institution continues its four decades of research into nutrition, obesity, and metabolic health, fields critical to addressing Louisiana's high rates of obesity and diabetes.
The Pennington Biomedical Research Center has conducted scientific research for four decades. The appointment follows a monthslong international search and a broader leadership shakeup within the LSU System.
The players
Petter Bjornstad
Incoming executive director currently serving as the head of the University of Washington Medicine Diabetes Institute.
Jennifer Rood
Interim senior vice chancellor and executive director managing the current leadership transition at the research center.
John Kirwan
Former executive director who departed the research center in December 2025.
Pennington Biomedical Research Center
A research institution based in Baton Rouge focusing on nutrition, obesity, and metabolic health.
LSU System
The public university system managing the center and overseeing its recent leadership reorganization.
The details
The recruitment process for the new executive director spanned multiple months and followed a leadership transition that began when John Kirwan stepped down in December 2025. Bjornstad brings expertise from his current role at the University of Washington Medicine Diabetes Institute to the center's focus on metabolic health. The transition marks the end of Jennifer Rood's service as the interim senior vice chancellor and executive director.
Timeline
December 2025: John Kirwan stepped down as executive director.
October 29, 2026: LSU announced the appointment of Petter Bjornstad.
June 30, 2027: Petter Bjornstad begins his new role.
Market Landscape
This appointment marks a strategic shift for the center following the 2025 LSU System leadership shakeup. The transition follows the pattern of consolidating specialized medical research leadership amid broader administrative restructuring.
Operators in the regional healthcare and life sciences sectors should monitor the transition for changes in collaborative research opportunities or local metabolic health initiatives. Businesses connected to the center’s clinical trial pipelines may anticipate new operational directives following the June 2027 start date.
The takeaway
The arrival of new leadership offers a signal for industry partners to review current research agreements before the mid-2027 transition. Monitoring public filings from the LSU System regarding future staffing changes will be key to understanding the center's long-term research trajectory.
Further reading
For more on shifts in local research and academic administration, visit People.
Live Poll
Should major research centers prioritize local health needs when choosing their leadership?
